A key role of C5a/C5aR activation for the development of sepsis

Journal of Leukocyte Biology

Volumn 74, Issue 6, 2003, Pages 966-970

  Riedemann, Niels C ^a   Guo, Ren Feng ^a   Ward, Peter A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Antibody; Complement; Cytokines; Inflammation; Innate immunity; LPS

Indexed keywords

ANAPHYLATOXIN; COMPLEMENT COMPONENT C5A; REACTIVE OXYGEN METABOLITE;

CELL TYPE; CHEMOTAXIS; COMPLEMENT ACTIVATION; ESCHERICHIA COLI; HUMAN; IMMUNE RESPONSE; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; RODENT; SEPSIS; SURVIVAL;

ANIMALS; CHEMOTAXIS; COMPLEMENT ACTIVATION; COMPLEMENT C5A; HUMANS; RECEPTOR, ANAPHYLATOXIN C5A; SEPSIS;

ESCHERICHIA COLI; NEGIBACTERIA; RODENTIA;

EID: 0346786461     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0403137     Document Type: Review

References (44)

1. Shin, H. S., Snyderman, R., Friedman, E., Mellors, A., Mayer, M. M. (1968) Chemotactic and anaphylatoxic fragment cleaved from the fifth component of guinea pig complement. Science 162, 361-363.
2. Goldstein, I. M., Weissmann, G. (1974) Generation of C5-derived lysosomal enzyme-releasing activity (C5a) by lysates of leukocyte lysosomes. J. Immunol. 113, 1583-1588.
3. Sacks, T., Moldow, C. F., Craddock, P. R., Bowers, T. K., Jacob, H. S. (1978) Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage. J. Clin. Invest. 61, 1161-1167.
4. Schumacher, W. A., Fantone, J. C., Kunkel, S. E., Webb, R. C., Lucchesi, B. R. (1991) The anaphylatoxins C3a and C5a are vasodilators in the canine coronary vasculature in vitro and in vivo. Agents Actions 34, 345-349.
5. Riedemann, N. C., Guo, R. F., Neff, T. A., Laudes, I. J., Keller, K. A., Sarma, V. J., Markiewski, M. M., Mastellos, D., Strey, C. W., Pierson, C. L., Lambris, J. D., Zetoune, F. S., Ward, P. A. (2002) Increased C5a receptor expression in sepsis. J. Clin. Invest. 110, 101-108.
6. Guo, R. F., Huber-Lang, M., Wang, X., Sarma, V., Padgaonkar, V. A., Craig, R. A., Riedemann, N. C., McClintock, S. D., Hlaing, T., Shi, M. M., Ward, P. A. (2000) Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis. J. Clin. Invest. 106, 1271-1280.
7. Gerard, N. P., Gerard, C. (1991) The chemotactic receptor for human C5a anaphylatoxin. Nature 349, 614-617.
8. Strachan, A. J., Woodruff, T. M., Haaima, G., Fairlie, D. P., Taylor, S. M. (2000) A new small molecule C5a receptor antagonist inhibits the reverse-passive Arthus reaction and endotoxic shock in rats. J. Immunol. 164, 6560-6565.
9. Arumugam, T. V., Shiels, I. A., Strachan, A. J., Abbenante, G., Fairlie, D. P., Taylor, S. M. (2003) A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats. Kidney Int. 63, 134-142.
10. Czermak, B. J., Sarma, V., Pierson, C. L., Warner, R. L., Huber-Lang, M., Bless, N. M., Schmal, H., Friedl, H. P., Ward, P. A. (1999) Protective effects of C5a blockade in sepsis. Nat. Med. 5, 788-792.
11. Bengtson, A., Heideman, M. (1988) Anaphylatoxin formation in sepsis. Arch. Surg. 123, 645-649.
12. Nakae, H., Endo, S., Inada, K., Takakuwa, T., Kasai, T., Yoshida, M. (1994) Serum complement levels and severity of sepsis. Res. Commun. Chem. Pathol. Pharmacol. 84, 189-195.
13. Nakae, H., Endo, S., Inada, K., Yoshida, M. (1996) Chronological changes in the complement system in sepsis. Surg. Today 26, 225-229.
14. Stevens, J. H., O'Hanley, P., Shapiro, J. M., Mihm, F. G., Satoh, P. S., Collins, J. A., Raffin, T. A. (1986) Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates. J. Clin. Invest. 77, 1812-1816.
15. Hangen, D. H., Stevens, J. H., Satoh, P. S., Hall, E. W., O'Hanley, P. T., Raffin, T. A. (1989) Complement levels in septic primates treated with anti-C5a antibodies. J. Surg. Res. 46, 195-199.
16. Smedegard, G., Cui, L. X., Hugli, T. E. (1989) Endotoxin-induced shock in the rat. A role for C5a. Am. J. Pathol. 135, 489-497.
17. Huber-Lang, M. S., Sarma, J. V., McGuire, S. R., Lu, K. T., Guo, R. F., Padgaonkar, V. A., Younkin, E. M., Laudes, I. J., Riedemann, N. C., Younger, J. G., Ward, P. A. (2001) Protective effects of anti-C5a peptide antibodies in experimental sepsis. FASEB J. 15, 568-570.
18. Huber-Lang, M., Sarma, V. J., Lu, K. T., McGuire, S. R., Padgaonkar, V. A., Guo, R. F., Younkin, E. M., Kunkel, R. G., Ding, J., Erickson, R., Curnutte, J. T., Ward, P. A. (2001) Role of C5a in multiorgan failure during sepsis. J. Immunol. 166, 1193-1199.
19. Huber-Lang, M., Younkin, E. M., Sarma, J. V., Riedemann, N., McGuire, S. R., Lu, K. T., Kunkel, R., Younger, J. G., Zetoune, F. S., Ward, P. A. (2002) Generation of C5a by phagocytic cells. Am. J. Pathol. 161, 1849-1859.
20. Huber-Lang, M. S., Riedeman, N. C., Sarma, J. V., Younkin, E. M., McGuire, S. R., Laudes, I. J., Lu, K. T., Guo, R. F., Neff, T. A., Padgaonkar, V. A., Lambris, J. D., Spruce, L., Mastellos, D., Zetoune, F. S., Ward, P. A. (2002) Protection of innate immunity by C5aR antagonist in septic mice. FASEB J. 16, 1567-1574.
21. Wetsel, R. A. (1995) Expression of the complement C5a anaphylatoxin receptor (C5aR) on non-myeloid cells. Immunol. Lett. 44, 183-187.
22. Drouin, S. M., Kildsgaard, J., Haviland, J., Zabner, J., Jia, H. P., McCray Jr., P. B., Tack, B. F., Welsel, R. A. (2001) Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma. J. Immunol. 166, 2025-2032.
23. Gasque, P., Singhrao, S. K., Neal, J. W., Gotze, O., Morgan, B. P. (1997) Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system. Am. J. Pathol. 150, 31-41.
24. Haviland, D. L., McCoy, R. L., Whitehead, W. T., Akama, H., Mohmenti, E. P., Brown, A., Haviland, J. C., Parks, W. C., Perlmutter, D. H., Wetsel, R. A. (1995) Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung. J. Immunol. 154, 1861-1869.
25. Laudes, I. J., Chu, J. C., Huber-Lang, M., Guo, R. F., Riedemann, N. C., Saturo, J. V., Mahdi, F., Murphy, H. S., Speyer, C., Lu, K. T., Lambris, J. Zetoune, F. S., Ward, P. A. (2002) Expression and function of C5a receptor in mouse microvascular endothelial cells. J. Immunol. 169, 5962-5970.
26. Riedemann, N. C., Neff, T. A., Guo, R. F., Bernacki, K. D., Landes, I. J., Sarma, J. V., Lambris, J. D., Ward, P. A. (2003) Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression. J. Immunol. 170, 503-507.
27. Riedemann, N. C., Guo, R. F., Bernacki, K. D., Reuben, J., Landes, I. J., Neff, T. A., Gao, H., Speyer, C., Sarma, J. V., Zetoune, F. S., Ward, P. A. (2003) Regulation by C5a of neutrophil activation during sepsis. Immunity, in press.
28. Montz, H., Koch, K. C., Zierz, R., Gotze, O. (1991) The role of C5a in interleukin-6 production induced by lipopolysaccharide or interleukiu-1. Immunology 74, 373-379.
29. Abe, K., Miyazaki, M., Koji, T., Furusu, A., Nakamura-Kurashige, T., Nishino, T., Ozono, Y., Harada, T., Sakai, H., Kolmo, S. (2001) Enhanced expression of complement C5a receptor mRNA in human diseased kidney assessed by in situ hybridization. Kidney Int. 60, 137-146.
30. Goldman, D. w., Enkel, H., Gifford, L. A., Chenoweth, D. E., Rosenbaum, J. T. (1986) Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonuclear leukocytes. J. Immunol. 137, 1971-1976.
31. Furebring, M., Hakansson, L. D., Venge, P., Nilsson, B., Sjolin, J. (2002) Expression of the C5a receptor (CD88) on granulocytes and monocytes in patients with severe sepsis. Crit. Care 6, 363-370.
32. Riedemann, N. C., Guo, R. F., Sarma, V. J. Laudes, I. J., Huber-Lang, M., Warner, R. L., Albrecht, E. A., Speyer, C. L. Ward, P. A. (2002) Expression and function of the C5a receptor in rat alveolar epithelial cells. J. Immunol. 168, 1919-1925.
33. Schindler, R., Gelfand, J. A., Dinarello, C. A. (1990) Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: translational signal provided by lipopolysaccharide or IL-1 itself. Blood 76, 1631-1638.
34. Kaspar, R. L., Gehrke, L. (1994) Peripheral blood mononuclear cells stimulated with C5a or lipopolysaccharide to synthesize equivalent levels of IL-1 beta mRNA show unequal IL-1 beta protein accumulation but similar polyribosome profiles. J. Immunol. 153, 277-286.
35. Strieter, R. M., Kasahara, K., Allen, R. M., Standiford, T. J., Rolfe, M. W., Becker, F. S., Chensue, S. W., Kunkel, S. L. (1992) Cytokine-induced neutrophil-derived interleukin-8. Am. J. Pathol. 141, 397-407.
36. Wittmann, M., Zwirner, J., Larsson, V. A., Kirchhoff, K., Begemann, G., Kapp, A., Gotze, O., Werfel, T. (1999) C5a suppresses the production of IL-12 by IFN-gamma-primed and lipopolysaccharide-challenged human monocytes. J. Immunol. 162, 6763-6769.
37. Kajita, T., Hugli, T. E. (1990) C5a-induced neutrophilia. A primary humoral mechanism for recruitment of neutrophils. Am. J. Pathol. 137, 467-477.
38. Solomkin, J. S., Jenkins, M. K., Nelson, R. D., Chenoweth, D., Simmons, R. L. (1981) Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation. Surgery 90, 319-327.
39. Huber-Lang, M. S., Younkin, E. M., Sarma, J. V., McGuire, S. R., Lu, K. T., Guo, R. F., Padgaonkar, V. A., Curnutte, J. T., Erickson, R., Ward, P. A. (2002) Complement-induced impairment of inmate immunity during sepsis. J. Immunol. 169, 3223-3231.
40. Guo, R. F., Riedemann, N. C., Laudes, I. J., Sarma, V. J., Kunkel, R. G., Dilley, K. A., Paulanskis, J. D., Ward, P. A. (2002) Altered neutrophil trafficking during sepsis. J. Immunol. 169, 307-314.
41. Laudes, I. J., Chu, J. C., Sikranth, S., Huber-Lang, M., Guo, R. F., Riedemann, N., Sarma, J. C., Schmaier, A. H., Ward, P. A. (2002) Anti-c5a ameliorates coagulation/fibrinolytic protein changes in a rat model of sepsis. Am. J. Pathol. 160, 1867-1875.
42. Riedemann, N. C., Guo, R. F., Laudes, I. J., Keller, K., Sarma, V. J., Padgaonkar, V., Zetoune, F. S., Ward, P. A. (2002) C5a receptor and thymocyte apoptosis in sepsis. FASEB J. 16, 887-888.
43. Hotchkiss, R. S., Tinsley, K. W., Swanson, P. E., Chang, K. C., Cobb, J. P., Buchman, T. G., Korsmeyer, S. J., Karl, I. E. (1999) Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc. Natl. Acad. Sci. USA 96, 14541-14546.
44. Hotchkis, R. S., Chang, K. C., Swanson, P. E., Timsley, K. W., Hui, J. J., Klender, P., Xanthoudakis, S., Roy, S., Black, C., Grimm, E., Aspiotis, R., Han, Y., Nicholson, D. W., Karl, I. E. (2000) Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat. Immunol. 1, 496-501.